NAP 226-90 |
Catalog No.GC47746 |
A metabolite of rivastigmine
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 139306-10-8
Sample solution is provided at 25 µL, 10mM.
NAP 226-90 is a metabolite of rivastigmine that is formed by hydrolysis.1
1.Polinsky, R.J.Clinical pharmacology of rivastigmine: A new-generation acetylcholinesterase inhibitor for the treatment of Alzheimer's diseaseClin. Ther.20(4)634-647(1998)
Review for NAP 226-90
Average Rating: 5
(Based on Reviews and 13 reference(s) in Google Scholar.)Review for NAP 226-90
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *